Some physicians are still skittish about prescribing generic drugs, but the manufacturers of these less expensive medicines say they are increasingly important and there is less need to worry about their quality and safety than ever before. Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association, tells the Chicago Tribune's Bruce Japsen about the generic industry's assurances of quality, as well as regulations that have helped this cause.
Improving the Safety of Generic Pharmaceuticals
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Some physicians are still skittish about prescribing generic drugs, but the manufacturers of these less expensive medicines say they are increasingly important and there is less need to worry about their quality and safety than ever before. Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association, tells the Chicago Tribune's Bruce Japsen about the generic industry's assurances of quality, as well as regulations that have helped this cause.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?